Qiagen (QGEN) Announces Receipt of FDA PMA for Therascreen EGFR Test for Use with IRESSA in NSCLC

July 13, 2015 3:47 PM

Qiagen (NASDAQ: QGEN) received U.S. marketing (PMA) approval of its therascreen EGFR RGQ PCR Kit (therascreen EGFR test) as a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found